BIOTRONIK Ilesto 7 Series Launched - Approved for MR scans

share Share
BIOTRONIK has recently launched its Ilesto 7 Series, the world’s first DF4 ICD/CRT heart implant series approved for MRI. The includes one of the world’s smallest ICDs while also offering the greatest longevity — up to 11.5 years for the single chamber ICD. 

“We see a rising need for MR scans at our clinic and nationwide, and we acknowledge the steps BIOTRONIK has taken to develop its ProMRI® technology in order to help thousands of patients obtain the diagnostics they desperately need,” explains Dr. Juan Gabriel Martinez, Head of the Arrhythmia Unit of Hospital General Alicante, Spain. 

Dr. Martinez implanted an Ilesto 7 HF-T in a 63-year-old patient suffering from cardiomyopathy. “Before BIOTRONIK launched its ProMRI® technology, patients with an ICD or CRT-D were prohibited from undergoing MR scans. Fortunately, with the new Ilesto system, I can offer my patients the option of an MR scan if they need one in the future. This is a very important aspect to my patients, as they have a high chance of needing an MR scan during the lifetime of their devices.” 

Different statistics show a rising need for MR scanning among CIED patients. The number of patients with ICDs continues to grow by 10 to 15 percent annually, and an estimated 50 to 75 percent of these patients will need an MR scan during the service lives of their devices. As patients live longer and frequently suffer comorbidities, a further increase is certain in the coming years. 

Patients also benefit from secure remote monitoring via BIOTRONIK Home Monitoring®, a unique feature that offers both patients and physicians the ultimate convenience: it does not require any patient interaction. BIOTRONIK Home Monitoring® is the first and only wireless remote system with both FDA and CE approval for early detection of clinically relevant events and reduction of in-office follow-ups. 

”With all our innovations, patient safety comes first,” notes Christoph Böhmer, President International of BIOTRONIK. “Our patients have the peace of mind that their device and thus their cardiac health is constantly being monitored through BIOTRONIK Home Monitoring®. In addition, Home Monitoring guided therapy has been shown to enable significant reduction of delivered shocks by 71 percent, as well as a reduction in hospitalization due to avoidance of inappropriate shocks by 73 percent.” 

Published on : Tue, 9 Jul 2013

Related Articles

A new technique for detecting cancer by imaging the consumption of sugar with magnetic resonance imaging (MRI) has been unveiled... Read more

Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) show that new software... Read more has announced a new market research report, Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018)... Read more

Cardiology, MRI BIOTRONIK has recently launched its Ilesto 7 Series, the world’s first DF4 ICD/CRT heart implant series approved for MRI. The includes one of the world�

No comment

Please login to leave a comment...

Highlighted Products